最終更新日:2024/07/31
A monoclonal antibody being developed for the treatment of type 1 diabetes and other autoimmune diseases.
正解を見る
otelixizumab
編集履歴(0)
A monoclonal antibody being developed for the treatment of type 1 diabetes and other autoimmune diseases.
otelixizumab